These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 21474803

  • 21. Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke.
    Sun YY, Morozov YM, Yang D, Li Y, Dunn RS, Rakic P, Chan PH, Abe K, Lindquist DM, Kuan CY.
    PLoS One; 2014; 9(6):e98807. PubMed ID: 24911517
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Therapeutic strategies for the treatment of stroke.
    Green AR, Shuaib A.
    Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
    [Abstract] [Full Text] [Related]

  • 24. Criteria for selection of older patients for thrombolytic therapy.
    Brockington CD, Lyden PD.
    Clin Geriatr Med; 1999 Nov; 15(4):721-39. PubMed ID: 10499932
    [Abstract] [Full Text] [Related]

  • 25. The free-radical scavenger edaravone accelerates thrombolysis with alteplase in an experimental thrombosis model.
    Yamashita T, Sato T, Sakamoto K, Ishii H, Yamamoto J.
    Thromb Res; 2015 Jun; 135(6):1209-13. PubMed ID: 25908261
    [Abstract] [Full Text] [Related]

  • 26. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J, Wersching H, Ringelstein EB, Schilling M, Schäbitz WR, Wellmann J, Berger K.
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [Abstract] [Full Text] [Related]

  • 27. The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature.
    Li R, Huang C, Chen J, Guo Y, Tan S.
    Neurol Sci; 2015 Jul; 36(7):1097-103. PubMed ID: 25772077
    [Abstract] [Full Text] [Related]

  • 28. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Jul; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 29. Edaravone: a new therapeutic approach for the treatment of acute stroke.
    Kikuchi K, Kawahara K, Miyagi N, Uchikado H, Kuramoto T, Morimoto Y, Tancharoen S, Miura N, Takenouchi K, Oyama Y, Shrestha B, Matsuda F, Yoshida Y, Arimura S, Mera K, Tada K, Yoshinaga N, Maenosono R, Ohno Y, Hashiguchi T, Maruyama I, Shigemori M.
    Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
    [Abstract] [Full Text] [Related]

  • 30. Progress in Intravenous Thrombolytic Therapy for Acute Stroke.
    Marshall RS.
    JAMA Neurol; 2015 Aug; 72(8):928-34. PubMed ID: 26030910
    [Abstract] [Full Text] [Related]

  • 31. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator.
    Tari Capone F, Cavallari M, Casolla B, Orzi F.
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298
    [Abstract] [Full Text] [Related]

  • 32. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR, NINDS rtPA Stroke Study Group.
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [Abstract] [Full Text] [Related]

  • 33. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L, Zhang ZG, Liu X, Hozeska A, Stagliano N, Riordan W, Lu M, Chopp M.
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [Abstract] [Full Text] [Related]

  • 34. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
    Fan X, Jiang Y, Yu Z, Yuan J, Sun X, Xiang S, Lo EH, Wang X.
    Adv Pharmacol; 2014 Jan; 71():391-410. PubMed ID: 25307224
    [Abstract] [Full Text] [Related]

  • 35. Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.
    Zhou H, Huang S, Sunnassee G, Guo W, Chen J, Guo Y, Tan S.
    Int J Neurosci; 2017 Nov; 127(11):1036-1046. PubMed ID: 28110588
    [Abstract] [Full Text] [Related]

  • 36. Uric acid enhances alteplase-mediated thrombolysis as an antioxidant.
    Kikuchi K, Setoyama K, Tanaka E, Otsuka S, Terashi T, Nakanishi K, Takada S, Sakakima H, Ampawong S, Kawahara KI, Nagasato T, Hosokawa K, Harada Y, Yamamoto M, Kamikokuryo C, Kiyama R, Morioka M, Ito T, Maruyama I, Tancharoen S.
    Sci Rep; 2018 Oct 26; 8(1):15844. PubMed ID: 30367108
    [Abstract] [Full Text] [Related]

  • 37. Extending the window for acute stroke treatment: thrombolytics plus CNS protective therapies.
    Wagner KR, Jauch EC.
    Exp Neurol; 2004 Aug 26; 188(2):195-9. PubMed ID: 15246819
    [No Abstract] [Full Text] [Related]

  • 38. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection.
    Amaro S, Planas AM, Chamorro A.
    Expert Rev Neurother; 2008 Feb 26; 8(2):259-70. PubMed ID: 18271711
    [Abstract] [Full Text] [Related]

  • 39. NXY-059 for acute ischemic stroke.
    Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW, Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators.
    N Engl J Med; 2006 Feb 09; 354(6):588-600. PubMed ID: 16467546
    [Abstract] [Full Text] [Related]

  • 40. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H, Sugimori H, Nanishi E, Nagata H, Lee S, Kuwashiro T, Hashizume M.
    J Stroke Cerebrovasc Dis; 2012 Nov 09; 21(8):903.e5-8. PubMed ID: 21421331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.